Tumeurs des glandes salivaires : OMS 2022 et au-delà - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Annales de Pathologie Année : 2024

Tumeurs des glandes salivaires : OMS 2022 et au-delà

Résumé

In 2022, the 5th edition of the WHO classification of Head and Neck tumors was published online. In the salivary gland chapter, a new benign entity, the keratocystoma, was introduced. The sclerosing polycystic adenosis has been recognized as tumoral and is now termed sclerosing polycystic adenoma. The striated duct adenoma now has its own dedicated chapter. Additionally, a new variant of pleomorphic adenoma, termed "canalicular adenoma-like," has been incorporated. Regarding malignant tumors of the salivary glands, significant doubts now exist regarding the actual existence of oncocytic carcinoma, which has been reclassified among emerging entities. Two new malignant entities have also emerged: microsecretory adenocarcinoma and microcystic sclerosing adenocarcinoma. Finally, primary mucinous adenocarcinoma of the salivary glands has been acknowledged as a distinct entity.

Dates et versions

inserm-04504919 , version 1 (14-03-2024)

Identifiants

Citer

Charles Lépine. Tumeurs des glandes salivaires : OMS 2022 et au-delà. Annales de Pathologie, 2024, Online ahead of print. ⟨10.1016/j.annpat.2024.02.005⟩. ⟨inserm-04504919⟩
1 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More